The SCL/TAL-1 gene encodes a basic helix-loop-helix transcription fact
or that is expressed in multipotent hematopoietic progenitors before l
ineage commitment. Its expression is maintained during differentiation
along erythroid, mast, and megakaryocytic lineages, but is repressed
after commitment to nonexpressing lineages. To begin to address the mo
lecular mechanisms underlying this complex pattern of expression, we h
ave studied the regulation of the murine SCL promoter in erythroid and
T-cell lines. Analysis of the methylation and chromatin structure of
the SCL promoter region showed that SCL mRNA expression correlated wit
h DNase hypersensitive sites and methylation status of the promoter. T
ransient reporter assays showed that promoter 1a was active in erythro
id cells but not in T cells. Sequences between -187 and +26 were suffi
cient for lineage-restricted activity of promoter 1a. A joint promoter
construct containing both promoter 1a and promoter Ib also exhibited
lineage-restricted activity. Conserved GATA (-37), MAZ (+242), and ETS
(+264) motifs were all shown to contribute to SCL promoter activity i
n erythroid cells, but several other motifs were not required for full
promoter activity. The pattern of complexes binding to the +242 MAZ a
nd +264 ETS sites were the same in erythroid and T cells. However, GAT
A-1 bound the -37 GATA site in erythroid cells, whereas in T cells GAT
A-3 was only able to bind weakly, if at all. Moreover, GATA-1 but not
GATA-2 or GATA-3 was able to transactivate SCL promoter 1a in a T-cell
environment. These results suggest that inactivity of SCL promoter 1a
in T cells reflected the absence of GATA-1 rather than the presence o
f trans-dominant negative regulators. (C) 1995 by The American Society
of Hematology.